Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
RMD Open|November 28, 2024
Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosisRucsandra Dobrota, Alexandru Garaiman, Kim Fligelstone, et al.
Clinical and Experimental Rheumatology|October 3, 2018
Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) databasePatricia E Carreira, Loreto Carmona, Beatriz E Joven, et al.
Clinical and Experimental Rheumatology|July 1, 2017
Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosisPatricia E Carreira, Loreto Carmona, Beatriz E Joven, et al.
Annals of the Rheumatic Diseases|November 26, 2021
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaireMike O Becker, Rucsandra Dobrota, Alexandru Garaiman, et al.
The Journal of Rheumatology|December 3, 2013
Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control studyEtienne Ghrénassia, Jérome Avouac, Dinesh Khanna, et al.
The Journal of Rheumatology|December 17, 2010
The functional polymorphism 844 A>G in FcαRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibilityJasper C A Broen, Marieke J H Coenen, Blanca Rueda, et al.
The Journal of Rheumatology|June 17, 2010
Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR)Behrooz Z Alizadeh, Jasper Broen, Blanca Rueda, et al.
Autoimmunity Reviews|January 14, 2020
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosisVanessa Smith, Ariane L Herrick, Francesca Ingegnoli, et al.
BMJ Open|March 19, 2021
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocolJulia Spierings, Anna van Rhenen, Paco Mw Welsing, et al.
Arthritis Research & Therapy|December 29, 2012
KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factorLara Bossini-Castillo, Carmen P Simeon, Lorenzo Beretta, et al.
Pageof 12